Evonik is a global leader for functional excipients and the formulation development and cGMP manufacturing of complex oral drug products. More than six decades of oral drug delivery expertise is now being applied to support the development and optimization of microbiota therapies and microbiome-based drug products.
In this webinar, industry experts will review how to improve the survival and stability of microbial products, and to better control transit and residence times to optimize performance. The webinar will discuss how products from the EUDRAGIT®
portfolio, as well as associated formulation services, can be applied across a broad range of established encapsulation process technologies from capsule filling to spray drying to help maximize safety, efficacy and patient adherence. A range of pH-, time- and microbial-dependent drug delivery technologies for modified release will also be reviewed regarding their ability to precisely target and optimize absorption within the colon or other microbiome sites.